What is Prime Medicine's operating lease liabilities?

Prime Medicine (PRME) reported operating lease liabilities of -$1.92M in Q1 2026.

How has Prime Medicine's operating lease liabilities changed year-over-year?

Prime Medicine's operating lease liabilities decreased by 200.2% year-over-year, from -$638K to -$1.92M.

What is the long-term trend for Prime Medicine's operating lease liabilities?

Over 3 years (2022 to 2025), Prime Medicine's operating lease liabilities has grown at a -19.4% compound annual growth rate (CAGR), from -$10.25M to -$5.36M.

Prime Medicine PRME Operating lease liabilities

Operating lease liabilities at other companies

Beam TherapeuticsBEAM

——

PVL

Palvella TherapeuticsPVLA

——

4D Molecular TherapeuticsFDMT

——

Immix Biopharma, Inc.IMMX

——

PrecigenPGEN

——

Iovance Biotherapeutics, Inc.IOVA

——

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's operating lease liabilities?: Prime Medicine (PRME) reported operating lease liabilities of -$1.92M in Q1 2026.
How has Prime Medicine's operating lease liabilities changed year-over-year?: Prime Medicine's operating lease liabilities decreased by 200.2% year-over-year, from -$638K to -$1.92M.
What is the long-term trend for Prime Medicine's operating lease liabilities?: Over 3 years (2022 to 2025), Prime Medicine's operating lease liabilities has grown at a -19.4% compound annual growth rate (CAGR), from -$10.25M to -$5.36M.